ALLIANCE PHARMA PLC

Notice of Dividend Amount • Nov 26, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1244H

Alliance Pharma PLC

26 November 2015

For immediate release                                                                                      26 November 2015

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Interim Dividend Timetable - Revised Record Date

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that in light of the announcement earlier today regarding the proposed acquisition of the Healthcare Products Business from Sinclair IS Pharma plc (the "Acquisition"), and the associated vendor placing, the Company is deferring the record date for its Interim Dividend to 29 December 2015 (from 18 December 2015). The payment date remains 14 January 2016, as announced in the Company's interim results on 9 September 2015.

This change accommodates any unexpected delay in completion of the Acquisition up to the long stop date of 28 December 2015 and ensures that placees receive the interim dividend to which they are entitled.

For further information:

Alliance Pharma plc
John Dawson, Chief Executive				+ 44 (0) 1249 466966
Numis Securities Limited
Nominated Adviser: Michael Meade / Freddie Barnfield				+ 44 (0) 20 7260 1000
Corporate Broking: David Poutney / James Black
Buchanan
Mark Court / Sophie Cowles / Jane Glover				+ 44 (0) 20 7466 5000

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCQQLFLEFFXFBB